-DOCSTART- -X- O
Nelfinavir -X- _ B-Intervention
( -X- _ I-Intervention
NFV -X- _ I-Intervention
) -X- _ I-Intervention
is -X- _ O
an -X- _ O
HIV-1 -X- _ O
aspartyl -X- _ O
protease -X- _ O
inhibitor -X- _ O
that -X- _ O
has -X- _ O
numerous -X- _ O
effects -X- _ O
on -X- _ O
human -X- _ O
cells -X- _ O
, -X- _ O
which -X- _ O
impart -X- _ O
attractive -X- _ O
antitumor -X- _ O
properties. -X- _ O
NFV -X- _ B-Outcome
has -X- _ I-Outcome
also -X- _ I-Outcome
been -X- _ I-Outcome
shown -X- _ I-Outcome
to -X- _ I-Outcome
have -X- _ I-Outcome
in -X- _ I-Outcome
vitro -X- _ I-Outcome
inhibitory -X- _ I-Outcome
activity -X- _ I-Outcome
against -X- _ I-Outcome
human -X- _ I-Outcome
herpesviruses -X- _ I-Outcome
( -X- _ I-Outcome
HHVs -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
Given -X- _ O
the -X- _ O
apparent -X- _ O
absence -X- _ O
of -X- _ O
an -X- _ O
aspartyl -X- _ O
protease -X- _ O
encoded -X- _ O
by -X- _ O
HHVs -X- _ O
, -X- _ O
we -X- _ O
investigated -X- _ O
the -X- _ O
mechanism -X- _ O
of -X- _ O
action -X- _ O
of -X- _ O
NFV -X- _ B-Intervention
herpes -X- _ B-Patient
simplex -X- _ I-Patient
virus -X- _ I-Patient
type -X- _ I-Patient
1 -X- _ I-Patient
( -X- _ I-Patient
HSV-1 -X- _ I-Patient
) -X- _ I-Patient
in -X- _ I-Patient
cultured -X- _ I-Patient
cells. -X- _ I-Patient
Selection -X- _ O
of -X- _ O
HSV-1 -X- _ O
resistance -X- _ O
to -X- _ O
NFV -X- _ O
was -X- _ O
not -X- _ O
achieved -X- _ O
despite -X- _ O
multiple -X- _ O
passages -X- _ O
under -X- _ O
drug -X- _ O
pressure. -X- _ O
NFV -X- _ B-Outcome
did -X- _ I-Outcome
not -X- _ I-Outcome
significantly -X- _ I-Outcome
affect -X- _ I-Outcome
the -X- _ I-Outcome
level -X- _ I-Outcome
of -X- _ I-Outcome
expression -X- _ I-Outcome
of -X- _ I-Outcome
late -X- _ I-Outcome
HSV-1 -X- _ I-Outcome
gene -X- _ I-Outcome
products. -X- _ I-Outcome
Normal -X- _ I-Outcome
numbers -X- _ I-Outcome
of -X- _ I-Outcome
viral -X- _ I-Outcome
particles -X- _ I-Outcome
appeared -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
produced -X- _ I-Outcome
in -X- _ I-Outcome
NFV-treated -X- _ I-Outcome
cells -X- _ I-Outcome
by -X- _ I-Outcome
electron -X- _ I-Outcome
microscopy -X- _ I-Outcome
but -X- _ I-Outcome
remain -X- _ I-Outcome
within -X- _ I-Outcome
the -X- _ I-Outcome
cytoplasm -X- _ I-Outcome
more -X- _ I-Outcome
often -X- _ I-Outcome
than -X- _ I-Outcome
controls. -X- _ I-Outcome
NFV -X- _ I-Outcome
did -X- _ I-Outcome
not -X- _ I-Outcome
inhibit -X- _ I-Outcome
the -X- _ I-Outcome
activity -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
HSV-1 -X- _ I-Outcome
serine -X- _ I-Outcome
protease -X- _ I-Outcome
nor -X- _ I-Outcome
could -X- _ I-Outcome
its -X- _ I-Outcome
antiviral -X- _ I-Outcome
activity -X- _ I-Outcome
be -X- _ I-Outcome
attributed -X- _ I-Outcome
to -X- _ I-Outcome
inhibition -X- _ I-Outcome
of -X- _ I-Outcome
Akt -X- _ I-Outcome
phosphorylation. -X- _ I-Outcome
NFV -X- _ I-Outcome
was -X- _ I-Outcome
found -X- _ I-Outcome
to -X- _ I-Outcome
decrease -X- _ I-Outcome
glycosylation -X- _ I-Outcome
of -X- _ I-Outcome
viral -X- _ I-Outcome
glycoproteins -X- _ I-Outcome
B -X- _ I-Outcome
and -X- _ I-Outcome
C -X- _ I-Outcome
and -X- _ I-Outcome
resulted -X- _ I-Outcome
in -X- _ I-Outcome
aberrant -X- _ I-Outcome
subcellular -X- _ I-Outcome
localization -X- _ I-Outcome
, -X- _ I-Outcome
consistent -X- _ I-Outcome
with -X- _ I-Outcome
induction -X- _ I-Outcome
of -X- _ I-Outcome
endoplasmic -X- _ I-Outcome
reticulum -X- _ I-Outcome
stress -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
unfolded -X- _ I-Outcome
protein -X- _ I-Outcome
response -X- _ I-Outcome
by -X- _ I-Outcome
NFV. -X- _ I-Outcome
These -X- _ O
results -X- _ O
demonstrate -X- _ O
that -X- _ O
NFV -X- _ B-Outcome
causes -X- _ I-Outcome
alterations -X- _ I-Outcome
in -X- _ I-Outcome
HSV-1 -X- _ I-Outcome
glycoprotein -X- _ I-Outcome
maturation -X- _ I-Outcome
and -X- _ O
egress -X- _ O
and -X- _ O
likely -X- _ O
acts -X- _ O
on -X- _ O
one -X- _ O
or -X- _ O
more -X- _ O
host -X- _ O
cell -X- _ O
functions -X- _ O
that -X- _ O
are -X- _ O
important -X- _ O
for -X- _ O
HHV -X- _ O
replication -X- _ O
. -X- _ O

